BiotequeROCO:4107 -0.43%84 Gross Margin % is 44.65% as of Dec. 2025, which is 2% above its 10-year median of 43.70. GuruFocus rates ROCO:4107 with a GF Score™ of 84/100 and a GF Value™ of NT$129.15 (Fairly Valued). Among 804 Medical Devices & Instruments companies, Bioteque ranks worse than 63.56% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Bioteque's Gross Profit for the
three
months ended in Dec. 2025 was NT$253 Mil. Bioteque's Revenue for the
three
months ended in Dec. 2025 was NT$567 Mil. Therefore, Bioteque's Gross Margin % for the quarter that ended in Dec. 2025 was 44.65%.
The historical rank and industry rank for Bioteque's Gross Margin % or its related term are showing as below:
ROCO:4107'
s Gross Margin % Range Over the Past 10 Years
Min: 42.01 Med: 43.7 Max: 44.49
Current: 43.88
During the past 13 years, the highestGross Margin % of Bioteque was 44.49%. The lowest was 42.01%. And the median was 43.70%.
ROCO:4107's Gross Margin % is ranked worse than 63.56% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 51.985
vs ROCO:4107: 43.88
Bioteque had a gross margin of 44.65% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Bioteque was 0.00% per year.
Bioteque (ROCO:4107) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bioteque had a gross margin of 44.65% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bioteque Gross Margin % Related Terms
Bioteque Gross Margin % Historical Data
* Premium members only.
The historical data trend for Bioteque's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4107 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Bioteque's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioteque Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bioteque's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bioteque (ROCO:4107) has a Gross Margin % of 44.65% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Bioteque and its competitors. This is near median its historical median of 43.70. Over the past decade, Bioteque's Gross Margin % has ranged from 42.01 to 44.49. According to the industry distribution chart, Bioteque ranks #511 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 63.6%.
Is Bioteque's Gross Margin % too high?
Bioteque's current Gross Margin % of 44.65% is near median its 10-year median of 43.70. Over the past 10 years, this metric has ranged from a low of 42.01 to a high of 44.49. The Medical Devices & Instruments industry median Gross Margin % is 51.99. Bioteque's value of 44.65% is 14.1% below this industry median. Based on the distribution chart, Bioteque ranks #511 out of 804 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bioteque has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bioteque ranks #511 out of 804 companies for Gross Margin %. This places Bioteque in the lower half of its industry. The industry median Gross Margin % is 51.99. Bioteque's value of 44.65% is 14.1% below this benchmark. Historically, Bioteque's own Gross Margin % has ranged from 42.01 to 44.49 over the past decade. While the company's 10-year median is 43.70 vs. the industry median of 51.99, Bioteque has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.99, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioteque's current Gross Margin % of 44.65% is 14.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Bioteque and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioteque's current Gross Margin % is 44.65%, which is near median its own 10-year median of 43.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Fairly Valued. The stock's GF Value™ is NT$129.15, compared to a current price of NT$117.00 — trading 9.4% below its estimated fair value. The current Gross Margin % is 44.65%, which is near median its 10-year median of 43.70 and 14.1% below the Medical Devices & Instruments industry median of 51.99. Bioteque's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current Gross Margin % is 44.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioteque (ROCO:4107) Overvalued in 2026?
Based on GuruFocus' analysis, Bioteque stock appears to be undervalued.
The current stock price of NT$117.00 is trading 9.4% below its estimated GF Value™ of NT$129.15.
GuruFocus considers Bioteque to be Fairly Valued.
Key valuation signals for ROCO:4107:
Gross Margin %: 44.65% (near median its 10-year median of 43.70)
GF Value™: NT$129.15 vs. price of NT$117.00 (9.4% below fair value)
Industry Position: 14.1% below the Medical Devices & Instruments median (#511 of 804)
No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
84GF Score
Get the complete analysis for ROCO:4107
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4107 has been successfully added to your 
